Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.7K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

543
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
543
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

633
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
633
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

494
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
494

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coexistent alterations of BAFF and B-cell phenotypes in complicated CVID course.

The Journal of allergy and clinical immunology·2026
Same author

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Heterozygous NFKB1 variant causes inflammatory dysregulation shaped by broader genetic context in common variable immunodeficiency.

JCI insight·2026
Same author

Diagnostic disparities in inborn errors of immunity: From clinical suspicion to diagnosis.

The journal of allergy and clinical immunology. Global·2025
Same author

Gut IgA functionally interacts with systemic IgG to enhance antipneumococcal vaccine responses.

Science advances·2025
Same author

Curation of gene-disease relationships in primary antibody deficiencies using the ClinGen validation framework.

The Journal of allergy and clinical immunology·2025

Related Experiment Video

Updated: Nov 16, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.5K

B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease.

Erik M Matson1, Miranda L Abyazi1, Kayla A Bell1

  • 1Pulmonary Center, Section of Pulmonary, Allergy, Sleep & Critical Care Medicine, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, United States.

Frontiers in Immunology
|February 22, 2021
PubMed
Summary

Common variable immunodeficiency (CVID) can cause interstitial lung disease (ILD). Understanding B cell dysregulation and BAFF signaling is crucial for managing CVID-ILD and improving patient outcomes.

Keywords:
B cell activating factorBAFF-RCVIDGLILDTACIcommon variable immune deficiencyinterstitial lung diseaserituximab

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

613
Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

3.6K

Related Experiment Videos

Last Updated: Nov 16, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.5K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

613
Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
09:00

Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment

Published on: June 24, 2020

3.6K

Area of Science:

  • Immunology
  • Pulmonology
  • Genetics

Background:

  • Common variable immunodeficiency (CVID) is a primary antibody deficiency with frequent non-infectious complications.
  • Interstitial lung disease (ILD) is a major cause of morbidity and mortality in CVID patients.
  • The exact mechanisms driving CVID-associated ILD remain poorly understood.

Purpose of the Study:

  • To explore the role of B cell dysregulation in the pathogenesis of CVID-ILD.
  • To investigate the potential involvement of B cell activating factor (BAFF) and its receptors in CVID-ILD.
  • To identify gaps in knowledge regarding B cell depletive therapy for CVID-ILD.

Main Methods:

  • Review of existing literature on CVID, ILD, and B cell biology.
  • Analysis of immune cell infiltration patterns in CVID ILD.
  • Examination of the BAFF signaling pathway and its receptors (BAFF-R, TACI, BCMA) in the context of CVID.

Main Results:

  • CVID ILD is characterized by significant pulmonary infiltration of T and B cells and often granulomatous inflammation.
  • B cell depletive therapy is a standard treatment, but its efficacy varies, and recurrence occurs.
  • Dysregulated B cell signaling networks, potentially involving BAFF, are implicated in CVID ILD pathogenesis.

Conclusions:

  • Further research into B cell biology is essential for understanding CVID-ILD development and progression.
  • Clarifying the role of BAFF and its receptors may lead to targeted therapies.
  • Optimizing the use of B cell depletive therapy requires a better understanding of patient heterogeneity and disease mechanisms.